CANCER.DOT.ORG
Guide to Cancer Information & Resources
Home
Endometrial Cancer
Thyroid Cancer
Hodgkin’s Lymphoma
Bladder Cancer
Renal Cancer (aka; Kidney Cancer)
Colorectal Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Melanoma (Skin Cancer)
Liver Cancer
Pancreatic Cancer
Cervical Cancer
Bladder Cancer
Brain Cancer (Brain Tumor)
Uterine Cancer
Ovarian Cancer
Leukemia (Blood Cancer)
Kidney Cancer
Oral Cancer (Mouth Cancer)
CANCER news:
UofL hosts annual Pink Game honoring breast cancer survivors - WHAS11
February 23, 2026
UofL hosts annual Pink Game honoring breast cancer survivors WHAS11
Cancer survivors, caregivers and neighbors hit the trails to honor a sister's legacy - 12News
February 22, 2026
Cancer survivors, caregivers and neighbors hit the trails to honor a sister's legacy 12News
How cancer care is evolving with modern medicine - BlackPressUSA
February 22, 2026
How cancer care is evolving with modern medicine BlackPressUSA
PENN STATE THON™ DELIVERS RECORD $18,841,726.53 FOR CHILDHOOD CANCER RESEARCH AND CARE - PR Newswire
February 22, 2026
PENN STATE THON™ DELIVERS RECORD $18,841,726.53 FOR CHILDHOOD CANCER RESEARCH AND CARE PR Newswire
Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy - Medical Xpress
February 22, 2026
Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy Medical Xpress
Another Penn State Thon record: $18.8M raised to help fight childhood cancer - Centre Daily Times
February 22, 2026
Another Penn State Thon record: $18.8M raised to help fight childhood cancer Centre Daily Times
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades - Nasdaq
February 22, 2026
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades Nasdaq
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades - The Motley Fool
February 22, 2026
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades The Motley Fool
ADC Ocular Toxicities in Ovarian Cancer Manageable, but Cataract Frequency Surprising - Oncology News Central
February 22, 2026
ADC Ocular Toxicities in Ovarian Cancer Manageable, but Cataract Frequency Surprising Oncology News Central
Genetic testing for cancer is becoming more common - St. Louis American
February 22, 2026
Genetic testing for cancer is becoming more common St. Louis American
Hodgkin’s Lymphoma
Leave a Reply
Click here to cancel your reply.
Name (required)
Mail (will not be published) (required)
Website
CANCER news:
UofL hosts annual Pink Game honoring breast cancer survivors - WHAS11
February 23, 2026
UofL hosts annual Pink Game honoring breast cancer survivors WHAS11
Cancer survivors, caregivers and neighbors hit the trails to honor a sister's legacy - 12News
February 22, 2026
Cancer survivors, caregivers and neighbors hit the trails to honor a sister's legacy 12News
How cancer care is evolving with modern medicine - BlackPressUSA
February 22, 2026
How cancer care is evolving with modern medicine BlackPressUSA
PENN STATE THON™ DELIVERS RECORD $18,841,726.53 FOR CHILDHOOD CANCER RESEARCH AND CARE - PR Newswire
February 22, 2026
PENN STATE THON™ DELIVERS RECORD $18,841,726.53 FOR CHILDHOOD CANCER RESEARCH AND CARE PR Newswire
Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy - Medical Xpress
February 22, 2026
Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy Medical Xpress
Another Penn State Thon record: $18.8M raised to help fight childhood cancer - Centre Daily Times
February 22, 2026
Another Penn State Thon record: $18.8M raised to help fight childhood cancer Centre Daily Times
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades - Nasdaq
February 22, 2026
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades Nasdaq
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades - The Motley Fool
February 22, 2026
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades The Motley Fool
ADC Ocular Toxicities in Ovarian Cancer Manageable, but Cataract Frequency Surprising - Oncology News Central
February 22, 2026
ADC Ocular Toxicities in Ovarian Cancer Manageable, but Cataract Frequency Surprising Oncology News Central
Genetic testing for cancer is becoming more common - St. Louis American
February 22, 2026
Genetic testing for cancer is becoming more common St. Louis American